Intratumoral genetic heterogeneity is well known, as is the role of preexisting mutations in
many documented cases of clinical relapse. But what is the extent of diversity and how does it …

… drug-resistant human immunodeficiency virus type 1 (HIV-1) can impair the response to
combination therapy. Widespread transmission of drug-resistant … rate of drug resistance in 2208 …

… of prevalence of HIV drug resistance in both treatment-naive and drug-experienced groups.
In the meantime, prevention of both occurrence and transmission of drug-resistant HIV is …

… study of antiretroviral drug resistance and are increasingly moving from the laboratory to
clinical practice. These techniques are able to detect HIV-1 drug resistance mutations present at …

… Finally, a minor attack-resistant subpopulation escapes and forms a clinically detectable …
Due to the correlation between CTCs/TICs and drug resistance and metastasis, we also …

… drug resistance in the early 1980s, we have accumulated a body of knowledge concerning
the clinical… Recently, an elucidation of the molecular aspects of antifungal drug resistance has …

… P-gp has also been widely associated with clinical drug resistance in preclinical models.
Overexpression of P-gp results in a significantly increased drug efflux and therefore decreased …

… such as pleiotropic drug resistance are providing insights into how multiple levels of drug
resistance occur and are yielding information on how certain types of drug resistance may be …

… of clinical trials and independent studies, clinicians have … of the incidence of drug resistance
and its clinical consequences. … resistance and the clinical consequences of viral resistance. …

… receptors and increased drug efflux. We present here comprehensively the drug resistance
in cancers … Also, apart from resistance to regularly used chemotherapeutic drugs, we present …